Both in Pharmaceuticals
Oragenics vs Propanc Biopharma
Over the past year OGEN returned −69.4% and PPCB returned −99.4%; their daily moves had a correlation of 0.09.
OGEN −69.4% PPCB −99.4%Growth of $1, one year, split-adjusted
| Metric | OGEN | PPCB |
|---|---|---|
| Price | $0.3490 | $1.64 |
| Market cap | $1.6M | $1.6M |
| Today | −6.18% | −8.38% |
| 1 month | −30.2% | −67.1% |
| 6 months | −43.1% | −92.9% |
| Year to date | −55.4% | −98.8% |
| 1 year | −69.1% | −99.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $3.9M | $832.0K |
| Dividend yield | — | — |
| Volatility (60d) | 51.5% | 730.0% |
| Short % of float | 24.4% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).